AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS: AXIM · Delayed Price · USD
0.0149
0.00 (0.00%)
Jul 26, 2024, 1:57 PM EDT - Market closed
AXIM Biotechnologies Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 - 2013 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 0.1 | 0.16 | 0.05 | 0.45 | 0.46 | 0.51 | Upgrade
|
| Short-Term Investments | - | - | - | - | - | 0.21 | Upgrade
|
| Cash & Short-Term Investments | 0.1 | 0.16 | 0.05 | 0.45 | 0.46 | 0.73 | Upgrade
|
| Cash Growth | 80.63% | 230.90% | -89.56% | -0.92% | -36.97% | -62.91% | Upgrade
|
| Prepaid Expenses | - | - | 0.04 | 0.16 | 0.26 | 0.08 | Upgrade
|
| Other Current Assets | - | - | 0.01 | 0.02 | - | 0.84 | Upgrade
|
| Total Current Assets | 0.1 | 0.16 | 0.1 | 0.64 | 0.71 | 1.64 | Upgrade
|
| Property, Plant & Equipment | 0.33 | 0.36 | 0.11 | 0.19 | 0.23 | 0 | Upgrade
|
| Goodwill | - | - | - | - | 2.46 | - | Upgrade
|
| Other Intangible Assets | 3.5 | 3.59 | 3.99 | 4.38 | - | - | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | 7.8 | - | Upgrade
|
| Other Long-Term Assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.05 | Upgrade
|
| Total Assets | 3.93 | 4.12 | 4.21 | 5.32 | 11.31 | 1.69 | Upgrade
|
| Accounts Payable | 1.62 | 2.78 | 1.32 | 0.85 | 0.76 | 0.75 | Upgrade
|
| Accrued Expenses | - | - | - | 0.06 | 0.31 | - | Upgrade
|
| Short-Term Debt | - | - | 0.03 | 1.61 | 0.37 | 0.04 | Upgrade
|
| Current Portion of Leases | 0.09 | 0.09 | 0.02 | 0.06 | 0.05 | - | Upgrade
|
| Current Unearned Revenue | 0.25 | 0.3 | 0.33 | - | - | - | Upgrade
|
| Other Current Liabilities | 2.84 | 2.8 | 1.7 | 0 | 0 | 2.6 | Upgrade
|
| Total Current Liabilities | 4.8 | 5.98 | 3.39 | 2.58 | 1.5 | 3.4 | Upgrade
|
| Long-Term Debt | 6.46 | 5.66 | 5.64 | 5.06 | 5.84 | 5.06 | Upgrade
|
| Long-Term Leases | 0.12 | 0.14 | - | 0.02 | 0.08 | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | - | 2.34 | - | Upgrade
|
| Total Liabilities | 11.38 | 11.78 | 9.04 | 7.66 | 9.75 | 8.45 | Upgrade
|
| Common Stock | 0.03 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 65.01 | 64.53 | 59.19 | 51 | 43.2 | 28.62 | Upgrade
|
| Retained Earnings | -72.48 | -72.18 | -64.13 | -57.88 | -41.85 | -35.44 | Upgrade
|
| Comprensive Income & Other | -0 | -0.02 | 0.09 | 4.53 | 0.2 | 0.05 | Upgrade
|
| Total Common Equity | -7.45 | -7.66 | -4.83 | -2.34 | 1.57 | -6.76 | Upgrade
|
| Shareholders' Equity | -7.45 | -7.66 | -4.83 | -2.34 | 1.57 | -6.76 | Upgrade
|
| Total Liabilities & Equity | 3.93 | 4.12 | 4.21 | 5.32 | 11.31 | 1.69 | Upgrade
|
| Total Debt | 6.67 | 5.89 | 5.69 | 6.75 | 6.34 | 5.1 | Upgrade
|
| Net Cash (Debt) | -6.57 | -5.74 | -5.64 | -6.3 | -5.88 | -4.37 | Upgrade
|
| Net Cash Per Share | -0.03 | -0.03 | -0.03 | -0.05 | -0.05 | -0.07 | Upgrade
|
| Filing Date Shares Outstanding | 291.46 | 278.43 | 223.65 | 152 | 128.86 | 128.44 | Upgrade
|
| Total Common Shares Outstanding | 278.43 | 245.93 | 192.44 | 138.1 | 125.33 | 64.85 | Upgrade
|
| Working Capital | -4.71 | -5.82 | -3.29 | -1.94 | -0.78 | -1.76 | Upgrade
|
| Book Value Per Share | -0.03 | -0.03 | -0.03 | -0.02 | 0.01 | -0.10 | Upgrade
|
| Tangible Book Value | -10.94 | -11.25 | -8.81 | -6.72 | -0.89 | -6.76 | Upgrade
|
| Tangible Book Value Per Share | -0.04 | -0.05 | -0.05 | -0.05 | -0.01 | -0.10 | Upgrade
|
| Machinery | 0.26 | 0.26 | 0.18 | 0.18 | 0.13 | 0.02 | Upgrade
|
Source: S&P Capital IQ. Standard template.